Document is current
Any future updates will be listed below
-
Authors
Xu, Yuhui
Hu, Jiali
Lv, Qiaoying
Shi, Chenyi
Qiu, Mengdi
Xie, Liying
Liu, Wei
Yang, Bingyi
Shan, Weiwei
Cheng, Yali
Zhao, Bing
Chen, Xiaojun https://orcid.org/0000-0002-5493-1500
-
Funding
Funding for this research was provided by:
National Key Research & Development Program of China (2019YFC1005200, 2019YFC1005203)
National Natural Science Foundation of China (82071611)
Science and Technology Innovation Plan Of Shanghai (20Z11900700)
- License Information
-
More Information
Article History
Received: 11 May 2022
Accepted: 25 May 2023
First Online: 7 June 2023
Declarations
:
: This study complied with the ARRIVE guidelines and the tenets of the Declaration of Helsinki and the National Guidelines for Animal Use in Research (China) for the reporting animal experiments. Animal experiments were approved by the Ethics Committees of Fudan University (Approval number: 201909008S; Title: Research and development of technologies related to fertility-preserving treatment in gynecological tumors; Date: September 23, 2019). Collection of human tissue samples was approved by the Ethics Committees of the Obstetrics and Gynecology Hospital of Fudan University (Approval number: 2019–129; Title: Research and development of technologies related to fertility-preserving treatment in gynecological tumors; Date: December 20, 2019).
: Not applicable.
: The authors declare no potential conflict of interest.
